Evidence map›Paper›PMID 29391340›Full record

ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2018

Effectiveness of Ankaferd BloodStopper in Prophylaxis and Treatment of Oral Mucositis in Childhood Cancers Evaluated with Plasma Citrulline Levels.

Türkan Patıroğlu, Nagihan Erdoğ Şahin, Ekrem Ünal, Mustafa Kendirci, Musa Karakükcü, Mehmet Akif Özdemir

Open access · diamondAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Antineoplastic Effects of Ankaferd Hemostat.BioMed research international · 2022
    Review
  3. Ankaferd hemostat: from molecules to medicineTurkish journal of medical sciences · 2020
    Review
  4. Article
  5. Article
  6. Article
  7. On Being a “Physician Patient” with His Own Experimental Therapeutic DrugTurkish journal of haematology : official journal of Turkish Society of Haematology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Türkan PatıroğluErciyes University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Kayseri, Turkey.
Nagihan Erdoğ ŞahinErciyes University Faculty of Medicine, Department of Pediatrics, Kayseri, Turkey.
Ekrem ÜnalErciyes University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Kayseri, Turkey.
Mustafa KendirciErciyes University Faculty of Medicine, Department of Pediatrics, Division of Metabolism, Kayseri, Turkey.
Musa KarakükcüErciyes University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Kayseri, Turkey.
Mehmet Akif ÖzdemirErciyes University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Kayseri, Turkey.
Erciyes University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CitrullineHumansMedicine, TraditionalNeoplasmsPlant ExtractsStomatitisTreatment Outcomeankaferd blood stopperCitrullinePlant ExtractsAnkaferd BloodStopper Citrulline.Childhood cancersOral mucositis

Identifiers

PMID29391340
PMCPMC5843785
OpenAlexW2769296373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.